Company Filing History:
Years Active: 1998-2010
Title: Mylene Lesenechal: Innovator in Monoclonal Antibodies and Chagas Disease Research
Introduction
Mylene Lesenechal is a prominent inventor based in Villeurbanne, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and methods for detecting infectious diseases. With a total of 5 patents to her name, her work has the potential to impact public health positively.
Latest Patents
One of her latest patents focuses on monoclonal antibodies directed against hepatitis B viruses. This invention relates to a monoclonal antibody capable of binding to a wild-type HBsAg antigen and to at least one, preferably at least two, and advantageously more than two mutant forms of the HBsAg antigen. The monoclonal antibody binds to a peptide sequence consisting of at least six contiguous amino acids in the 199-208 region of the HBsAg antigen, and advantageously binds to the peptide sequence constituted by the 199-208 region of the HBsAg antigen. Another significant patent involves the Trypanosoma cruzi antigen, which describes the nucleotide sequence of Tc100, a gene encoding PTc100, a new Trypanosoma antigen. This invention provides methods for detecting and treating Chagas disease, which can be crucial for monitoring infections in humans and animals.
Career Highlights
Mylene has worked with notable companies in the biotechnology sector, including bioMérieux, Inc. and bioMérieux SA. Her experience in these organizations has allowed her to develop her expertise in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Mylene has collaborated with esteemed colleagues such as Glaucia Paranhos-Baccala and Michel C. Jolivet. These partnerships have further enriched her research and innovation efforts.
Conclusion
Mylene Lesenechal is a remarkable inventor whose work in monoclonal antibodies and infectious disease detection showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against diseases like hepatitis B and Chagas disease.